[1]赵沐华 周帆 穆军升.冠状动脉旁路移植术后高敏心肌肌钙蛋白水平与预后危险因素评估价值的临床研究进展[J].心血管病学进展,2024,(11):989.[doi:10.16806/j.cnki.issn.1004-3934.2024.11.007]
 ZHAO Muhua,ZHOU Fan,MU Junsheng.Evaluation Value of High-Sensitivity Troponin Levels and Prognostic Risk Factors After Coronary Artery Bypass Grafting[J].Advances in Cardiovascular Diseases,2024,(11):989.[doi:10.16806/j.cnki.issn.1004-3934.2024.11.007]
点击复制

冠状动脉旁路移植术后高敏心肌肌钙蛋白水平与预后危险因素评估价值的临床研究进展()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2024年11期
页码:
989
栏目:
综述
出版日期:
2024-11-25

文章信息/Info

Title:
Evaluation Value of High-Sensitivity Troponin Levels and Prognostic Risk Factors After Coronary Artery Bypass Grafting
作者:
赵沐华1 周帆 2 穆军升 34
(1.首都医科大学,北京 100069;2.解放军总医院第三医学中心超声科,北京 100039;3.首都医科大学附属北京安贞医院 北京市心肺血管疾病研究所心脏外科,北京 100029;4.新乡医学院第三附属医院心脏外科,河南 新乡 453000)
Author(s):
ZHAO Muhua1ZHOU Fan 2MU Junsheng 34
(1.Capital Medical University,Beijing 100069,China; 2. Department of Ultrasound,The Third Medical Center of Peoples Liberation Army of China General Hospital,Beijing 100039,China ; 3.Department of Cardiac Surgery,Beijing Anzhen Hospital,Capital Medical University,Beijing Institute of Heart Lung and Blood Vessel Diseases,Beijing 100029,China; 4.Department of Cardiac Surgery,The Third Affili ated Hospital of Xinxiang Medical University,Xinxiang 453000,Henan,China)
关键词:
冠状动脉旁路移植术高敏心肌肌钙蛋白预后评估危险因素
Keywords:
Coronary artery bypass graftingHigh-sensitivity troponinPrognostic assessmentRisk factor
DOI:
10.16806/j.cnki.issn.1004-3934.2024.11.007
摘要:
冠状动脉旁路移植术(CABG)是治疗冠心病的有效手段,但手术风险及术后并发症的存在使得预后评估显得尤为重要。高敏心肌肌钙蛋白作为心肌损伤的重要生物标志物,在CABG后患者预后评估中发挥重要作用。现综述近年来关于CABG后高敏心肌肌钙蛋白水平与预后危险因素评估价值的研究进展,旨在为临床实践和预后评估提供科学依据。
Abstract:
Coronary artery bypass grafting(CABG) is an effective method for treating coronary heart disease,but the presence of surgical risks and postoperative complications make prognostic evaluation particularly important. High-sensitivity troponin,as an important biomarker of myocardial injury,plays an important role in the prognosis evaluation of patients after CABG. This article reviews the research progress in recent years on the evaluation value of high-sensitivity troponin levels and prognostic risk factors after CABG,aiming to provide scientific basis for clinical practice and prognostic evaluation

参考文献/References:

[1] Cummins B,Auckland ML,Cummins P. Cardiac-specific troponin-l radioimmunoassay in the diagnosis of acute myocardial infarction[J]. Am Heart J,1987,113(6):1333-1344.

[2] Katus HA,Remppis A,Looser S,et al. Enzyme linked immuno assay of cardiac troponin T for the detection of acute myocardial infarction in patients[J]. J Mol Cell Cardiol,1989,21(12):1349-1353.

[3] Wu AH,Apple FS,Gibler WB,et al. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases[J]. Clin Chem,1999,45(7):1104-1121.

[4] Thygesen K,Alpert JS,White HD. Universal definition of myocardial infarction[J]. J Am Coll Cardiol,2007,50(22):2173-2195.

[5] Lurati Buse GA,Koller MT,Grapow M,et al. The prognostic value of troponin release after adult cardiac surgery—A meta-analysis[J]. Eur J Cardio thorac Surg,2010,37(2):399-406.

[6] Thygesen K,Alpert JS,Jaffe AS,et al. Fourth universal definition of myocardial infarction(2018)[J]. J Am Coll Cardiol,2018,72(18):2231-2264.

[7] Thielmann M,Sharma V,Al-Attar N,et al. ESC Joint Working Groups on Cardiovascular Surgery and the Cellular Biology of the Heart Position Paper:perioperative myocardial injury and infarction in patients undergoing coronary artery bypass graft surgery[J]. Eur Heart J,2017,38(31):2392-2407.

[8] Moussa ID,Klein LW,Shah B,et al. Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization:an expert consensus document from the Society for Cardiovascular Angiography and Interventions(SCAI)[J]. J Am Coll Cardiol,2013,62(17):1563-1570.

[9] Garcia-Garcia HM,McFadden EP,Farb A,et al. Standardized end point definitions for coronary intervention trials:The Academic Research Consortium-2 Consensus Document[J]. Eur Heart J,2018,39(23):2192-2207.

[10] Garg P,Morris P,Fazlanie AL,et al. Cardiac biomarkers of acute coronary syndrome:from history to high-sensitivity cardiac troponin[J]. Intern Emerg Med,2017,12(2):147-155.

[11] Wu AH,Fukushima N,Puskas R,et al. Development and preliminary clinical validation of a high sensitivity assay for cardiac troponin using a capillary flow(single molecule) fluorescence detector[J]. Clin Chem,2006,52(11):2157-2159.

[12] Anand A,Shah ASV,Beshiri A,et al. Global adoption of high-sensitivity cardiac troponins and the universal definition of myocardial infarction[J]. Clin Chem,2019,65(3):484-489.

[13] Katus HA,Remppis A,Scheffold T,et al. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction[J]. Am J Cardiol,1991,67(16):1360-1367.

[14] Starnberg K,Jeppsson A,Lindahl B,et al. Revision of the troponin T release mechanism from damaged human myocardium[J]. Clin Chem,2014,60(8):1098-1104.

[15] Heuts S,Gollmann-Tepek?ylü C,Denessen EJS,et al. Cardiac troponin release following coronary artery bypass grafting:mechanisms and clinical implications[J]. Eur Heart J,2023,44(2):100-112.

[16] Omran H,Deutsch MA,Groezinger E,et al. High-sensitivity cardiac troponin I after coronary artery bypass grafting for post-operative decision-making[J]. Eur Heart J,2022,43(25):2388-2403.

[17] P?lzl L,Engler C,Sterzinger P,et al. Association of high-sensitivity cardiac troponin T with 30-day and 5-year mortality after cardiac surgery[J]. J Am Coll Cardiol,2023,82(13):1301-1312.

[18] Lu P,Lu X,Li B,et al. High-sensitivity cardiac troponin T in prediction and diagnosis of early postoperative hypoxemia after off-pump coronary artery bypass grafting[J]. J Cardiovasc Dev Dis,2022,9(12):416.

[19] Heuts S,Denessen EJS,Daemen JHT,et al. Meta-analysis evaluating high-sensitivity cardiac troponin T kinetics after coronary artery bypass grafting in relation to the current definitions of myocardial infarction[J]. Am J Cardiol,2022,163:25-31.

[20] Devereaux PJ,Lamy A,Chan MTV,et al. High-sensitivity troponin I after cardiac surgery and 30-day mortality[J]. N Engl J Med,2022,386(9):827-836.

[21] Friedman T,Leviner DB,Chan V,et al. High sensitivity troponin-I threshold to predict perioperative myocardial infarction[J]. J Cardiothorac Surg,2023,18(1):234.

[22] Nanni S,Garofalo M,Schinzari M,et al. Prognostic value of high-sensitivity cardiac troponin I early after coronary artery bypass graft surgery[J]. J Cardiothorac Surg,2022,17(1):280.

[23] Kalaria TR,Harris N,Sensi H,et al. High-sensitivity cardiac troponin I:is ethnicity relevant?[J]. J Clin Pathol,2021,74(11):709-711.

[24] Saha A,Patel KV,Ayers C,et al. Longitudinal changes in cardiac troponin and risk of heart failure among black adults[J]. J Card Fail,2023,29(1):6-15.

[25] Liu C,Deng Z,Wu W,et al. Ethnicity and sex-specific 99th percentile upper reference limits of high-sensitivity cardiac troponin I among adults in Xinjiang,China[J]. Clin Biochem,2023,116:94-99.

[26] Hickman PE,Abhayaratna WP,Potter JM,et al. Age-related differences in hs-cTnI concentration in healthy adults[J]. Clin Biochem,2019,69:26-29.

[27] Clerico A,Aimo A,Cantinotti M. High-sensitivity cardiac troponins in pediatric population[J]. Clin Chem Lab Med,2022,60(1):18-32.

[28] Kimenai DM,Janssen EBNJ,Eggers KM,et al. Sex-specific versus overall clinical decision limits for cardiac troponin I and T for the diagnosis of acute myocardial infarction:a systematic review[J]. Clin Chem,2018,64(7):1034-1043.

[29] Kimenai DM,Shah ASV,McAllister DA,et al. Sex differences in cardiac troponin I and T and the prediction of cardiovascular events in the general population[J]. Clin Chem,2021,67(10):1351-1360.

[30] Zaninotto M,Padoan A,Mion MM,et al. Short-term biological variation and diurnal rhythm of cardiac troponin I(Access hs-TnI) in healthy subjects[J]. Clin Chim Acta,2020,504:163-167.

[31] Roffi M,Patrono C,Collet JP,et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation:Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology(ESC)[J]. Eur Heart J,2016,37(3):267-315.

[32] Twerenbold R,Neumann JT,S?rensen NA,et al. Prospective validation of the 0/1-h algorithm for early diagnosis of myocardial infarction[J]. J Am Coll Cardiol,2018,72(6):620-632.

[33] Koechlin L,Boeddinghaus J,Nestelberger T,et al. Lower diagnostic accuracy of hs-cTnI in patients with prior coronary artery bypass grafting[J]. Int J Cardiol,2022,354:1-6.

[34] Ashburn NP,Snavely AC,O’Neill JC,et al. Performance of the European Society of Cardiology 0/1-hour algorithm with high-sensitivity cardiac troponin T among patients with known coronary artery disease[J]. JAMA Cardiol,2023,8(4):347-356.

相似文献/References:

[1]齐弘炜,袁彪.中国常用动脉化冠状动脉旁路移植术的通畅率及疗效[J].心血管病学进展,2015,(5):559.[doi:10.3969/j.issn.1004-3934.2015.05.009]
 QI Hongwei,YUAN Biao.Effects and Patency of Coronary Artery Bypass Grafting Used in China[J].Advances in Cardiovascular Diseases,2015,(11):559.[doi:10.3969/j.issn.1004-3934.2015.05.009]
[2]马琛 陈少敏 崔鸣.冠状动脉慢性完全闭塞病变治疗研究进展[J].心血管病学进展,2020,(4):333.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.001]
 MA Chen,CHEN Shaomin,CUI Ming.Treatment in Patients with Coronary Chronic Total Occlusion[J].Advances in Cardiovascular Diseases,2020,(11):333.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.001]
[3]奚云萍 臧雁翔 李为民.临床SYNTAX计分及其衍生计分在冠心病血运重建预后中的应用价值[J].心血管病学进展,2020,(5):452.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.004]
 XI Yunping,ZANG Yanxiang,LI Weimin.Value of Clinical SYNTAX Score and Its Derivative Score in Prognosis of Coronary Artery Disease with Revascularization[J].Advances in Cardiovascular Diseases,2020,(11):452.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.004]
[4]孙一博 孙莉萍 董建增.血管炎的冠状动脉风险及手术治疗进展[J].心血管病学进展,2020,(8):821.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.010]
 SUN YiboSUN LipingDONG Jianzeng.Coronary Risk and Progress in Surgical Therapy of Vasculitis[J].Advances in Cardiovascular Diseases,2020,(11):821.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.010]
[5]程悦 孟维鑫 康凯.被动选择还是主动获取?——谈“No-Touch”大隐静脉获取术的产生及研究进展[J].心血管病学进展,2020,(9):934.[doi:10.16806/j.cnki.issn.1004-3934.2020.09.012]
 CHENG Yue,MENG Weixin,KANG Kai.Passive Selection or Active Accessthe Emergence and Research Progress of "No-touch" Technique for Great Saphenous Vein Graft[J].Advances in Cardiovascular Diseases,2020,(11):934.[doi:10.16806/j.cnki.issn.1004-3934.2020.09.012]
[6]魏倩 梁岩.高敏心肌肌钙蛋白在急性冠脉综合征患者中的临床应用进展[J].心血管病学进展,2021,(5):396.[doi:10.16806/j.cnki.issn.1004-3934.2021.05.003]
[7]马浩 张世成 宋仰午 黄思源 赵栋 凤玮.单纯冠状动脉旁路移植术治疗左心室室壁瘤的回顾性队列研究[J].心血管病学进展,2023,(5):465.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.019]
 MA Hao,ZHANG Shicheng,SONG Yangwu,et al.Surgical Effects of Coronary Artery Bypass Grafting Alone for Patients with Left Ventricular Aneurysm:A Retrospective Cohort Study[J].Advances in Cardiovascular Diseases,2023,(11):465.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.019]

更新日期/Last Update: 2024-12-02